TREA

79245402 - SIPORE

Follow

Information

  • Trademark
  • 79245402
  • Serial Number
    79245402
  • Registration Number
    5999045
  • Filing Date
    June 01, 2018
    7 years ago
  • Registration Date
    March 03, 2020
    5 years ago
  • Transaction Date
    April 24, 2025
    a month ago
  • Status Date
    March 03, 2020
    5 years ago
  • Published for Opposition Date
    December 17, 2019
    5 years ago
  • Location Date
    March 03, 2020
    5 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    INGRAM,KYLE G
  • Attorney Name
    Bradley L. Cohn
    Law Office Assigned Location Code
    N70
  • Owners
Information
Mark Drawing Code
4
Mark Identification
SIPORE
Case File Statements
  • GS0051: Dietetic preparations adapted for medical use; dietetic substances in the nature of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions adapted for medical use; pharmaceuticals and natural remedies for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; preparations for use in naturopathy for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; nutritional supplements; chemical preparations for medical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and chemico- pharmaceutical preparations for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; dietary and nutritional supplements; health food supplements for persons with special dietary requirements; chemical preparations for pharmaceutical purposes for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; pharmaceutical preparations and substances for glycemic control; pharmaceutical preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietetic preparations and substances for glycemic control; dietetic preparations and substances for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; dietary and nutritional supplements for glycemic control; dietary and nutritional supplements for the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in glycemic control; pharmaceutical preparations in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions for use in the prevention and treatment of prediabetes, diabetes and for the improvement of overall metabolic health; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, colitis; pharmaceutical preparations and substances, dietary and nutritional substances in the form of tablets, capsules, liquid formulations, drinks, shots, shakes, gels, powders and suspensions, all for use in the treatment and regulation of intestinal injury or inflammation, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients, and not including products primarily for use in the treatment of angina pectoris and high blood pressure
  • GS0101: Surgical and medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; capsulated medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; medical devices for the treatment and prevention of obesity and being overweight, and for use in weight control; medical devices for the treatment and prevention of prediabetes, diabetes and glycemic control, and for the improvement of overall metabolic health; medical devices for use in the prevention and treatment of prediabetes and diabetes; orally administered medical devices for the treatment and prevention of obesity, being overweight, prediabetes, diabetes, glycemic control and for the improvement of overall metabolic health; surgical and medical devices, capsulated devices and orally administered medical devices all for use in the treatment and regulation of obesity, body weight, body fat, body composition, body weight circumference, cholesterol and LDL cholesterol levels, liver disease, steatohepatitis, infantile colic, gut microbiota, insulin levels and resistance, blood lipids, diarrhea, constipation, intestinal injury or inflammation, colitis, Crohn's disease, cardiovascular risk factors, post bariatric surgery patients
Case File Event Statements
  • 11/19/2018 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/15/2018 - 6 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 11/19/2018 - 6 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/20/2018 - 6 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 11/21/2018 - 6 years ago
    5 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 11/23/2018 - 6 years ago
    6 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 12/4/2018 - 6 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 12/4/2018 - 6 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 12/21/2018 - 6 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 2/1/2019 - 6 years ago
    10 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 2/7/2019 - 6 years ago
    11 - LIMITATION FROM THE IB - REQUEST EXAM REVIEW Type: LIME
  • 2/8/2019 - 6 years ago
    12 - ATTORNEY REVIEW COMPLETED Type: ATRV
  • 6/3/2019 - 6 years ago
    13 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/3/2019 - 6 years ago
    14 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/4/2019 - 6 years ago
    15 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/13/2019 - 5 years ago
    16 - FINAL REFUSAL WRITTEN Type: CNFR
  • 6/13/2019 - 5 years ago
    17 - FINAL REFUSAL E-MAILED Type: GNFR
  • 6/13/2019 - 5 years ago
    18 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 11/4/2019 - 5 years ago
    19 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 11/4/2019 - 5 years ago
    20 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/5/2019 - 5 years ago
    21 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/10/2019 - 5 years ago
    22 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/17/2019 - 5 years ago
    27 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 11/14/2019 - 5 years ago
    23 - ASSIGNED TO LIE Type: ALIE
  • 11/27/2019 - 5 years ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 12/4/2019 - 5 years ago
    25 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 12/4/2019 - 5 years ago
    26 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 12/17/2019 - 5 years ago
    28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 12/20/2019 - 5 years ago
    29 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 3/3/2020 - 5 years ago
    30 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/8/2020 - 4 years ago
    32 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 6/3/2020 - 5 years ago
    31 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/18/2025 - a month ago
    38 - CHANGE OF NAME/ADDRESS REC'D FROM IB Type: ADCH
  • 7/8/2020 - 4 years ago
    33 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 7/24/2020 - 4 years ago
    34 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 1/29/2023 - 2 years ago
    35 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 4/2/2023 - 2 years ago
    36 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 3/3/2025 - 3 months ago
    37 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3